MAPT and Alzheimer disease: Nevertheless, the presence of these SNPs does not predict the occurrence of AD, nor does it correlate with various AD endophenotypes such as memory impairment, total tau, Aβ1-42, or tau phosphorylated at threonine 181 levels [129,130].